Life Science Company
Incyte has acquired 3 companies, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms.
Incyte’s largest acquisition to date was in 2016, when it acquired Ariad Pharmaceuticals - Iclusig Business for $140M. Incyte has acquired in 2 different US states. The Company’s most targeted sectors include life science (67%) and information services (34%).
Join Mergr and gain access to Incyte’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 2